European Equities Traded in the US as ADRs Rise in Wednesday Trading

MT Newswires Live
Sep 03

European equities traded in the US as American depositary receipts rose late Wednesday morning with the S&P Europe Select ADR Index gaining 0.4% to 1,513.01.

From continental Europe, the gainers were led by internet browser company Opera (OPRA) and furniture manufacturer Natuzzi (NTZ), which climbed 11% and 8.6% respectively. They were followed by medical device maker EDAP TMS (EDAP) and telecommunications company Nokia (NOK), which advanced 7.6% and 4.4% respectively.

The decliners from continental Europe were led by petroleum refiner Equinor (EQNR) and biotech firm Evaxion (EVAX), which declined 3% and 2.6% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and brewing company Anheuser-Busch InBev (BUD), which lost 2.4% and 2.1% respectively.

From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics (AUTL) and pharmaceutical company Silence Therapeutics (SLN), which rose 6% and 5.9% respectively. They were followed by cruise line operator Carnival (CUK) and biopharmaceutical company NuCana (NCNA), which were up 1.5% and 1.3% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Adaptimmune Therapeutics (ADAP), which shed 7.1% and 4.5% respectively. They were followed by education company Pearson (PSO) and oil and gas company BP (BP), which were down 3.1% and 1.9% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10